SCHEMBL3165176

SCHEMBL3165176

CC(=O)NCCNc1cc(NCCNC(=O)c2ccc(C)cc2)nc(-c2ccccc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.57
LMNA P02545 2/20 0.57
ADORA2A P29274 2/20 0.50
ADORA1 P30542 2/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
ALDH1A1 P00352 5/20 0.48
CYP1A2 P05177 5/20 0.48
CYP3A4 P08684 5/20 0.48
CLK4 Q9HAZ1 4/20 0.48
MAPK1 P28482 2/20 0.48
ALOX15 P16050 2/20 0.48
HSD17B10 Q99714 2/20 0.48
USP2 O75604 2/20 0.47
MAPT P10636 3/20 0.46
ADORA3 P0DMS8 2/20 0.45
TSHR P16473 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163394 0.93 ADORA1 (0.51) POLBLMNAADORA2AADORA1KMT2A
SCHEMBL3168663 0.92 ADORA1 (0.48) POLBLMNAADORA2AADORA1SMN1; SMN2
SCHEMBL3162824 0.91 ADORA1 (0.47) POLBLMNAADORA2AADORA1SMN1; SMN2
SCHEMBL3168745 0.89 ADORA2A (0.56) LMNAADORA2AADORA1MEN1KMT2A
SCHEMBL3156240 0.89 RAB9A (0.51) POLBLMNAADORA2AADORA1SMN1; SMN2
SCHEMBL3155352 0.89 ALDH1A1 (0.47) LMNAADORA2AADORA1MEN1KMT2A
SCHEMBL3170298 0.89 ADORA2A (0.46) POLBLMNAADORA2AADORA1MEN1
SCHEMBL3174346 0.89 NPC1 (0.53) POLBLMNAADORA2AADORA1MEN1
SCHEMBL3163156 0.89 RAB9A (0.48) POLBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL3164826 0.88 CYP3A4 (0.49) LMNAADORA2AADORA1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed